Treatment group | n | Gender (n (%)) | Age (years) | Anx coil (n (%)) | Anx stent coil (n (%)) | Anx Onyx embo (n (%)) | Anx PED (n (%)) | Extracranial carotid angioplasty and stenting (n (%)) | Intracranial carotid angioplasty and stenting (n (%)) | dAVF coil embo (n (%)) |
Aspirin and clopidogrel | 55 | 11 M (20) | 61.2±12.4 | 17 (30.9) | 22 (40.0) | 3 (5.5) | 7 (12.7) | 3 (5.5) | 2 (3.6) | 1 (1.8) |
44 F (80) | ||||||||||
Aspirin and prasugrel | 31 | 7 M (23) | 59.4±14.8 | 5 (16.1) | 8 (25.8) | 3 (9.7) | 9 (29.0) | 6 (19.4) | 0 (0) | 0 (0) |
24 F (77) | ||||||||||
p Value | 0.565 | 0.198 | 0.241 | 0.663 | 0.084 | 0.065 | – | – |
Anx, aneurysm; dAVF, dural arteriovenous fistula; embo, embolization; PED, pipeline embolization device.